Lung Cancer: Therapeutic Modalities and Cytoprotection

@article{Schiller1998LungCT,
  title={Lung Cancer: Therapeutic Modalities and Cytoprotection},
  author={Joan Hoff Schiller},
  journal={Lung},
  year={1998},
  volume={176},
  pages={145-164}
}
Lung cancer is the leading cancer killer in the United States today. The current methods of treatment, radiation and various chemotherapies, have been used with some success; however, early detection remains the key to successful therapy. Current clinical trials indicate that an improvement of available therapies is needed. Consequently, the development of new approaches to treatment is foremost in the minds of researchers. Advances in molecular medicine have produced new drugs that can protect… CONTINUE READING
4 Citations
98 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 98 references

Hoppener F for the EORTC Head and Neck Cooperative Group (1996) Randomized phase II study of weekly cisplatin with or without amifostine in patients with advanced head and neck cancer

  • AST Planting, JB Vermorken, G Catimel, PHM de Mulder, A de Graeff, W Oster
  • Ann Oncol
  • 1996
1 Excerpt

Phase II activity of gemcitabine in combination with cisplatin in advanced non–small cell lung cancer

  • A Antón, A Carrato, +7 authors E Lo ́pez-Martin
  • Proc ASCO 15:380,A1134
  • 1996
1 Excerpt

Similar Papers

Loading similar papers…